Endo Health Solutions (ENDP +7.1%) names Rajiv De Silva , who had been president of Valeant Pharmaceuticals International (VRX +0.6%), as it's president and CEO, effective March 18. De Silva, who will also join the Endo board of directors, succeeds its retiring current CEO David Holveck. The announcement eclipses a downgrade by Jefferies to Underweight, citing persistent uncertainty over the extent of generic competition on Opana ER and Lidoderm.
Are you Bullish or Bearish on ?
Results for ()
Thanks for sharing your thoughts.
From other sites
at Zacks.com (Mon, 10:22AM)
at Zacks.com (Mon, 8:29AM)
at MarketWatch.com (Mon, 7:57AM)
at Zacks.com (Fri, 4:18PM)
at Zacks.com (Fri, 8:40AM)
ETF Screener: Search and filter by asset class, strategy, theme, performance, yield, and much more
ETF Performance: View ETF performance across key asset classes and investing themes
ETF Investing Guide: Learn how to build and manage a well-diversified, low cost ETF portfolio
ETF Selector: An explanation of how to select and use ETFs